Key facts
- Notable investors include TopoScend Capital, VI Ventures, Hyfinity Investments.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Human Metabolomics Institute
- ·The full record, as it builds
Funding rounds
No funding rounds for Human Metabolomics Institute are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Human Metabolomics Institute
Provider and researcher of chronic disease diagnosis intended to serve the healthcare industry. The company is mainly focused on the research and development of the In vitro diagnostic kits, intelligent assistance software and health drinks, providing clients with industry-leading standard products.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2017
- Website
- hmibiotech.com/
- Ownership
- Privately Held (backing)
Human Metabolomics Institute doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Human Metabolomics Institute shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Human Metabolomics Institute in its N-PORT filings yet. We sweep new filings monthly.